U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 212295

BYFAVO (REMIMAZOLAM BESYLATE)
EQ 20MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: REMIMAZOLAM BESYLATE
Proprietary Name: BYFAVO
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 20MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N212295
Product Number: 001
Approval Date: Oct 6, 2020
Applicant Holder Full Name: ACACIA PHARMA LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top